| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 35 | 2024 | 352 | 4.710 |
Why?
|
| RNA-Binding Proteins | 12 | 2024 | 305 | 3.430 |
Why?
|
| Monocarboxylic Acid Transporters | 26 | 2024 | 86 | 2.720 |
Why?
|
| Membrane Transport Proteins | 17 | 2017 | 170 | 2.670 |
Why?
|
| Triiodothyronine | 27 | 2024 | 362 | 2.500 |
Why?
|
| Selenoproteins | 9 | 2024 | 22 | 2.130 |
Why?
|
| Thyroid Gland | 14 | 2024 | 281 | 2.110 |
Why?
|
| Mutation | 34 | 2024 | 4374 | 1.880 |
Why?
|
| Symporters | 22 | 2024 | 112 | 1.840 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 13 | 2022 | 118 | 1.680 |
Why?
|
| Congenital Hypothyroidism | 12 | 2023 | 80 | 1.600 |
Why?
|
| Iodide Peroxidase | 18 | 2023 | 215 | 1.550 |
Why?
|
| Hyperthyroidism | 5 | 2022 | 76 | 1.490 |
Why?
|
| Thyroxine | 25 | 2024 | 388 | 1.390 |
Why?
|
| Muscular Atrophy | 8 | 2024 | 48 | 1.370 |
Why?
|
| Muscle Hypotonia | 10 | 2024 | 49 | 1.290 |
Why?
|
| Thyroid Hormone Receptors beta | 12 | 2023 | 83 | 1.150 |
Why?
|
| Thyrotropin | 20 | 2024 | 311 | 1.110 |
Why?
|
| Phenotype | 15 | 2024 | 2578 | 1.110 |
Why?
|
| Pedigree | 21 | 2024 | 982 | 1.010 |
Why?
|
| Thyroid Diseases | 8 | 2020 | 106 | 0.960 |
Why?
|
| Hypothyroidism | 8 | 2024 | 276 | 0.950 |
Why?
|
| Mutation, Missense | 7 | 2020 | 302 | 0.840 |
Why?
|
| Graves Disease | 1 | 2022 | 36 | 0.750 |
Why?
|
| Endocrinology | 1 | 2022 | 50 | 0.730 |
Why?
|
| Mice, Knockout | 20 | 2020 | 2161 | 0.700 |
Why?
|
| Zinc | 1 | 2021 | 101 | 0.690 |
Why?
|
| Thyroid Neoplasms | 2 | 2023 | 443 | 0.690 |
Why?
|
| Selenium | 4 | 2021 | 46 | 0.630 |
Why?
|
| Thyroid Function Tests | 13 | 2021 | 124 | 0.600 |
Why?
|
| Male | 59 | 2024 | 45863 | 0.590 |
Why?
|
| Fusion Regulatory Protein 1, Light Chains | 3 | 2014 | 6 | 0.560 |
Why?
|
| Amino Acid Transport System y+ | 3 | 2014 | 10 | 0.560 |
Why?
|
| Receptors, Thyroid Hormone | 6 | 2019 | 160 | 0.500 |
Why?
|
| Iron-Binding Proteins | 3 | 2021 | 16 | 0.480 |
Why?
|
| Humans | 74 | 2024 | 96105 | 0.480 |
Why?
|
| Female | 56 | 2024 | 50028 | 0.480 |
Why?
|
| Thyroglobulin | 4 | 2020 | 59 | 0.480 |
Why?
|
| Child, Preschool | 17 | 2024 | 3974 | 0.460 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 2534 | 0.450 |
Why?
|
| Autoantigens | 3 | 2021 | 139 | 0.450 |
Why?
|
| Child | 18 | 2024 | 7625 | 0.440 |
Why?
|
| Cell Membrane | 2 | 2013 | 695 | 0.410 |
Why?
|
| Antithyroid Agents | 3 | 2024 | 23 | 0.400 |
Why?
|
| Animals | 34 | 2024 | 28891 | 0.400 |
Why?
|
| Diiodothyronines | 4 | 2015 | 12 | 0.400 |
Why?
|
| Propionates | 4 | 2015 | 36 | 0.390 |
Why?
|
| Cerebral Cortex | 3 | 2014 | 615 | 0.390 |
Why?
|
| Heterozygote | 8 | 2021 | 382 | 0.390 |
Why?
|
| Propylthiouracil | 2 | 2024 | 27 | 0.380 |
Why?
|
| Adolescent | 16 | 2024 | 9895 | 0.380 |
Why?
|
| Thyroid Dysgenesis | 2 | 2022 | 10 | 0.370 |
Why?
|
| Energy Metabolism | 2 | 2015 | 312 | 0.370 |
Why?
|
| Mice | 23 | 2024 | 12537 | 0.360 |
Why?
|
| Autoimmune Diseases | 2 | 2013 | 257 | 0.350 |
Why?
|
| Adipose Tissue | 1 | 2013 | 269 | 0.340 |
Why?
|
| Infant | 12 | 2024 | 3363 | 0.320 |
Why?
|
| Syndrome | 2 | 2010 | 453 | 0.310 |
Why?
|
| Thyrotropin, beta Subunit | 3 | 2020 | 10 | 0.290 |
Why?
|
| Mutagenesis, Insertional | 2 | 2020 | 116 | 0.290 |
Why?
|
| Brain | 8 | 2020 | 2482 | 0.290 |
Why?
|
| Liver | 7 | 2017 | 1238 | 0.280 |
Why?
|
| Triiodothyronine, Reverse | 3 | 2019 | 32 | 0.280 |
Why?
|
| Genotype | 10 | 2023 | 1881 | 0.280 |
Why?
|
| Placenta | 2 | 2023 | 191 | 0.280 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2024 | 308 | 0.270 |
Why?
|
| Biological Transport | 6 | 2014 | 412 | 0.270 |
Why?
|
| Homozygote | 5 | 2018 | 208 | 0.270 |
Why?
|
| Antioxidants | 1 | 2009 | 232 | 0.270 |
Why?
|
| Hyperthyroxinemia, Familial Dysalbuminemic | 2 | 2018 | 8 | 0.250 |
Why?
|
| Adult | 19 | 2024 | 28721 | 0.250 |
Why?
|
| Receptors, Thyrotropin | 3 | 2012 | 48 | 0.240 |
Why?
|
| Genes, erbA | 2 | 2023 | 11 | 0.240 |
Why?
|
| Chorea | 1 | 2005 | 14 | 0.230 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2005 | 38 | 0.220 |
Why?
|
| Pregnancy | 11 | 2023 | 3240 | 0.220 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2024 | 50 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2024 | 66 | 0.210 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 110 | 0.210 |
Why?
|
| Intellectual Disability | 1 | 2005 | 203 | 0.210 |
Why?
|
| Microsatellite Repeats | 1 | 2024 | 151 | 0.210 |
Why?
|
| Drug Therapy, Combination | 2 | 2024 | 813 | 0.200 |
Why?
|
| Diiodotyrosine | 1 | 2023 | 3 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 3489 | 0.190 |
Why?
|
| Terminology as Topic | 2 | 2014 | 229 | 0.190 |
Why?
|
| Dual Oxidases | 2 | 2020 | 15 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 139 | 0.180 |
Why?
|
| Sodium Compounds | 1 | 2021 | 3 | 0.180 |
Why?
|
| Arsenites | 1 | 2021 | 7 | 0.180 |
Why?
|
| Deficiency Diseases | 1 | 2021 | 12 | 0.180 |
Why?
|
| Thyroidectomy | 1 | 2022 | 173 | 0.180 |
Why?
|
| Research | 1 | 2022 | 265 | 0.170 |
Why?
|
| Cattle | 2 | 2020 | 386 | 0.170 |
Why?
|
| Selenocysteine | 1 | 2020 | 2 | 0.170 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2020 | 22 | 0.170 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 97 | 0.170 |
Why?
|
| Fetal Therapies | 1 | 2020 | 6 | 0.170 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2019 | 176 | 0.160 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2017 | 78 | 0.160 |
Why?
|
| Chromogranins | 1 | 2020 | 11 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2020 | 19 | 0.160 |
Why?
|
| Alu Elements | 1 | 2020 | 16 | 0.160 |
Why?
|
| Dietary Supplements | 2 | 2011 | 133 | 0.160 |
Why?
|
| Animals, Newborn | 4 | 2014 | 535 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2024 | 591 | 0.150 |
Why?
|
| Fibroblasts | 5 | 2019 | 777 | 0.150 |
Why?
|
| Insulin Resistance | 1 | 2021 | 380 | 0.150 |
Why?
|
| Young Adult | 6 | 2021 | 7025 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2020 | 196 | 0.140 |
Why?
|
| Serum Albumin, Human | 1 | 2018 | 5 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2018 | 67 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2019 | 2090 | 0.140 |
Why?
|
| Serum Albumin | 2 | 2018 | 128 | 0.140 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1791 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 442 | 0.130 |
Why?
|
| Fetal Diseases | 2 | 2017 | 81 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2021 | 873 | 0.130 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 559 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 2061 | 0.130 |
Why?
|
| Organic Anion Transporters | 2 | 2013 | 26 | 0.130 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 188 | 0.130 |
Why?
|
| Insulin | 1 | 2021 | 1190 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2017 | 280 | 0.120 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 273 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1267 | 0.110 |
Why?
|
| Sudan | 3 | 2020 | 13 | 0.110 |
Why?
|
| Arabs | 2 | 2012 | 17 | 0.110 |
Why?
|
| Thyroxine-Binding Globulin | 1 | 2015 | 6 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 555 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 356 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2020 | 2494 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 483 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2020 | 2474 | 0.100 |
Why?
|
| Cerebrum | 1 | 2013 | 15 | 0.100 |
Why?
|
| Body Composition | 1 | 2013 | 75 | 0.100 |
Why?
|
| Middle Aged | 8 | 2021 | 28368 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2014 | 131 | 0.100 |
Why?
|
| Adipose Tissue, Brown | 1 | 2013 | 96 | 0.100 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 208 | 0.100 |
Why?
|
| Kinetics | 3 | 2020 | 1562 | 0.100 |
Why?
|
| Diet | 2 | 2021 | 460 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 273 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 411 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 87 | 0.090 |
Why?
|
| Autophagy | 1 | 2014 | 175 | 0.090 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2011 | 33 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2019 | 170 | 0.090 |
Why?
|
| Isoenzymes | 2 | 2015 | 278 | 0.090 |
Why?
|
| Obesity | 1 | 2018 | 1030 | 0.090 |
Why?
|
| Hyperthyroxinemia | 1 | 2011 | 17 | 0.090 |
Why?
|
| Acute Lung Injury | 1 | 2011 | 68 | 0.080 |
Why?
|
| Zebrafish | 1 | 2013 | 342 | 0.080 |
Why?
|
| Family Health | 3 | 2018 | 159 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2010 | 13 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2014 | 683 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2022 | 10287 | 0.080 |
Why?
|
| Dependovirus | 2 | 2022 | 37 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 223 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2019 | 3581 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2010 | 233 | 0.080 |
Why?
|
| Molecular Structure | 1 | 2010 | 310 | 0.080 |
Why?
|
| Infant, Newborn | 5 | 2020 | 2614 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 897 | 0.070 |
Why?
|
| PAX8 Transcription Factor | 2 | 2022 | 24 | 0.070 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 80 | 0.070 |
Why?
|
| Paired Box Transcription Factors | 2 | 2022 | 50 | 0.070 |
Why?
|
| Drug Resistance | 2 | 2006 | 237 | 0.070 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2008 | 11 | 0.070 |
Why?
|
| Base Sequence | 4 | 2006 | 2344 | 0.070 |
Why?
|
| Family | 2 | 2020 | 332 | 0.070 |
Why?
|
| Skin | 3 | 2005 | 605 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2020 | 336 | 0.070 |
Why?
|
| Alleles | 4 | 2015 | 1157 | 0.070 |
Why?
|
| Pituitary Gland | 1 | 2007 | 118 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 69 | 0.060 |
Why?
|
| Transcription Factors | 3 | 2012 | 1730 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 910 | 0.060 |
Why?
|
| Mosaicism | 1 | 2006 | 74 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 136 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2006 | 120 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2020 | 547 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2006 | 80 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 1619 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1667 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 2537 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1230 | 0.060 |
Why?
|
| Response Elements | 1 | 2005 | 65 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2020 | 703 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 1069 | 0.060 |
Why?
|
| Siblings | 1 | 2005 | 109 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 74 | 0.060 |
Why?
|
| Lung | 1 | 2011 | 1384 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 301 | 0.050 |
Why?
|
| Biomarkers | 2 | 2021 | 1930 | 0.050 |
Why?
|
| Glycolysis | 1 | 2005 | 191 | 0.050 |
Why?
|
| Cholesterol | 1 | 2006 | 369 | 0.050 |
Why?
|
| Nystagmus, Congenital | 1 | 2003 | 2 | 0.050 |
Why?
|
| Point Mutation | 1 | 2004 | 247 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2003 | 33 | 0.050 |
Why?
|
| Exons | 2 | 2002 | 454 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 750 | 0.050 |
Why?
|
| Monoiodotyrosine | 1 | 2023 | 5 | 0.050 |
Why?
|
| Primates | 1 | 2024 | 160 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2017 | 908 | 0.050 |
Why?
|
| Serogroup | 1 | 2022 | 12 | 0.050 |
Why?
|
| Fetus | 1 | 2023 | 239 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 1979 | 0.050 |
Why?
|
| Thyroxine-Binding Proteins | 1 | 2002 | 86 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 51 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2001 | 90 | 0.040 |
Why?
|
| Haplotypes | 2 | 2015 | 650 | 0.040 |
Why?
|
| Eye | 1 | 2001 | 112 | 0.040 |
Why?
|
| Head | 1 | 2001 | 131 | 0.040 |
Why?
|
| Early Medical Intervention | 1 | 2020 | 19 | 0.040 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2020 | 9 | 0.040 |
Why?
|
| Megalencephaly | 1 | 2020 | 21 | 0.040 |
Why?
|
| Amniotic Fluid | 1 | 2020 | 30 | 0.040 |
Why?
|
| Heredity | 1 | 2020 | 20 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 701 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2020 | 137 | 0.040 |
Why?
|
| Consanguinity | 2 | 2015 | 73 | 0.040 |
Why?
|
| Models, Biological | 1 | 2007 | 1809 | 0.040 |
Why?
|
| Constipation | 1 | 2020 | 69 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2011 | 692 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2020 | 368 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 83 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 1320 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2017 | 2480 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 164 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 109 | 0.040 |
Why?
|
| Goiter | 1 | 2018 | 45 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2010 | 2939 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2003 | 824 | 0.040 |
Why?
|
| Romania | 3 | 2014 | 6 | 0.040 |
Why?
|
| Turkey | 1 | 2018 | 22 | 0.040 |
Why?
|
| Thyroid Nuclear Factor 1 | 2 | 2012 | 13 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2010 | 677 | 0.040 |
Why?
|
| Israel | 2 | 2012 | 64 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 706 | 0.030 |
Why?
|
| Exome | 1 | 2018 | 141 | 0.030 |
Why?
|
| Australia | 1 | 2018 | 124 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 1010 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 3927 | 0.030 |
Why?
|
| Placental Circulation | 1 | 2017 | 11 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2017 | 76 | 0.030 |
Why?
|
| Bone Development | 1 | 2017 | 38 | 0.030 |
Why?
|
| Fetal Development | 1 | 2017 | 35 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2017 | 66 | 0.030 |
Why?
|
| Drosophila | 1 | 2001 | 539 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1133 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 152 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 325 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2001 | 523 | 0.030 |
Why?
|
| Mothers | 1 | 2017 | 155 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 2090 | 0.030 |
Why?
|
| Protein Folding | 1 | 2018 | 295 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1957 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1349 | 0.030 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2015 | 5 | 0.030 |
Why?
|
| Drinking | 1 | 2015 | 35 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2015 | 1429 | 0.030 |
Why?
|
| Pakistan | 1 | 2015 | 17 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 103 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2015 | 116 | 0.030 |
Why?
|
| Glycine | 1 | 2015 | 96 | 0.030 |
Why?
|
| Arginine | 1 | 2015 | 144 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 165 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 297 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2014 | 24 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 224 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2016 | 382 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 215 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2013 | 3 | 0.030 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2013 | 5 | 0.030 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2013 | 13 | 0.030 |
Why?
|
| COS Cells | 2 | 2004 | 168 | 0.020 |
Why?
|
| Bangladesh | 1 | 2014 | 339 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3639 | 0.020 |
Why?
|
| Compassionate Use Trials | 1 | 2012 | 6 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 1963 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1993 | 196 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2012 | 65 | 0.020 |
Why?
|
| Amino Acids | 1 | 1993 | 262 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2015 | 935 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 183 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 95 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 57 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 149 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2007 | 996 | 0.020 |
Why?
|
| Founder Effect | 1 | 2012 | 106 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 77 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 297 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 9175 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 372 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 1375 | 0.020 |
Why?
|
| Child Development | 1 | 2012 | 174 | 0.020 |
Why?
|
| Methimazole | 1 | 2010 | 13 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 171 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 99 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 707 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 144 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4028 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2012 | 505 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 303 | 0.020 |
Why?
|
| Neurogranin | 1 | 2009 | 3 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1124 | 0.020 |
Why?
|
| DNA | 2 | 2006 | 1333 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 2086 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 399 | 0.020 |
Why?
|
| Rats, Inbred Dahl | 1 | 2007 | 8 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2007 | 37 | 0.020 |
Why?
|
| Cytokines | 1 | 2011 | 871 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 180 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1828 | 0.020 |
Why?
|
| Chromosomes | 1 | 2007 | 104 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 186 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1973 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 147 | 0.020 |
Why?
|
| Introns | 1 | 2007 | 304 | 0.020 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2005 | 2 | 0.010 |
Why?
|
| Chromones | 1 | 2005 | 31 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1988 | 489 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2005 | 18 | 0.010 |
Why?
|
| Leukemia | 1 | 1988 | 328 | 0.010 |
Why?
|
| Morpholines | 1 | 2005 | 77 | 0.010 |
Why?
|
| Cytosol | 1 | 2005 | 198 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 1984 | 16 | 0.010 |
Why?
|
| Skin Physiological Phenomena | 1 | 2004 | 27 | 0.010 |
Why?
|
| Dimerization | 1 | 2004 | 150 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2005 | 134 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1984 | 75 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 1083 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 930 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 394 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1535 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 1984 | 69 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 351 | 0.010 |
Why?
|
| Threonine | 1 | 2003 | 34 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 56 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 5961 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 656 | 0.010 |
Why?
|
| Chromosome Segregation | 1 | 2002 | 35 | 0.010 |
Why?
|
| Ectoderm | 1 | 2001 | 31 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2002 | 58 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2001 | 107 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 4155 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2001 | 184 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1220 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 426 | 0.010 |
Why?
|
| Vertebrates | 1 | 2001 | 113 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 605 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 1653 | 0.010 |
Why?
|
| Body Patterning | 1 | 2001 | 217 | 0.010 |
Why?
|
| Aged | 3 | 2014 | 20968 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2002 | 290 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2778 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 793 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2001 | 447 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 829 | 0.010 |
Why?
|
| Periodontal Diseases | 1 | 1978 | 10 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3040 | 0.010 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1993 | 11 | 0.010 |
Why?
|
| Trace Elements | 1 | 1993 | 11 | 0.010 |
Why?
|
| Minerals | 1 | 1993 | 21 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 1993 | 37 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1993 | 214 | 0.010 |
Why?
|
| Vitamins | 1 | 1993 | 86 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1971 | 35 | 0.010 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1971 | 30 | 0.010 |
Why?
|
| Rosette Formation | 1 | 1988 | 33 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 326 | 0.000 |
Why?
|
| Acute Disease | 1 | 1988 | 872 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1988 | 327 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 51 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1984 | 64 | 0.000 |
Why?
|
| Time Factors | 1 | 1993 | 5580 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1984 | 1179 | 0.000 |
Why?
|
| Gingiva | 1 | 1978 | 8 | 0.000 |
Why?
|
| Mouth Mucosa | 1 | 1978 | 71 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1978 | 281 | 0.000 |
Why?
|
| Acidosis | 1 | 1971 | 56 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1971 | 509 | 0.000 |
Why?
|